A vs APLS: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Apellis Pharmaceuticals Inc in 2026
A
Agilent Technologies Inc
$120.75
APLS
Apellis Pharmaceuticals Inc
$40.88
Key Metrics Comparison
| Metric | A | APLS | Winner |
|---|---|---|---|
| Market Cap | $34.05B | $5.22B | A |
| P/E Ratio | 25.89 | 226.94 | A |
| EPS (TTM) | $4.65 | $0.18 | A |
| Revenue Growth | 0.1% | -0.1% | A |
| Gross Margin | 52.3% | 60.3% | APLS |
Analyze A
Full quant analysis
Analyze APLS
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or APLS a better investment?
Comparing A and APLS: Agilent Technologies Inc has a market cap of $34.05B while Apellis Pharmaceuticals Inc has $5.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and APLS?
A (Agilent Technologies Inc) and APLS (Apellis Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or APLS?
Based on P/E ratios, A trades at a lower multiple (25.9x vs 226.9x).
Which is growing faster: A or APLS?
A has higher revenue growth at 0.1% vs -0.1% for APLS.
Which company is more profitable: A or APLS?
Apellis Pharmaceuticals Inc (APLS) has higher gross margins at 60.3% compared to 52.3% for A.
Which is the larger company: A or APLS?
Agilent Technologies Inc (A) is larger with a market cap of $34.05B compared to $5.22B for APLS.
Should I buy A or APLS in 2026?
Both A and APLS have investment merit. A trades at $120.75 while APLS trades at $40.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and APLS stock?
Key differences: Market Cap ($34.05B vs $5.22B), P/E Ratio (25.9x vs 226.9x), Revenue Growth (0.1% vs -0.1%), Gross Margin (52.3% vs 60.3%).